There are 2789 resources available
726MO - Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)
Presenter: Nicoletta Colombo
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
LBA34 - Association of homologous recombination deficiency (HRD) with clinical outcomes in a phase III study of olaparib or cediranib and olaparib compared to platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (PSOC): Biomarker analyses from NRG-GY004
Presenter: Joyce Liu
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
795MO - Pembrolizumab (pembro) in patients (pts) with microsatellite instability-high (MSI-H) advanced endometrial cancer (EC): Updated results from KEYNOTE-158
Presenter: David O'Malley
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Webcast
Discussion 578MO and 579MO
Presenter: Giulia Baciarello
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Slides
Webcast
Discussion 7MO, 1801MO and 1802MO
Presenter: Christian Ottensmeier
Session: Mini oral session - Basic science
Resources:
Slides
Webcast
Discussion 723MO and 724MO
Presenter: Ana Oaknin
Session: Mini oral session - Gynaecological cancers
Resources:
Slides
Webcast
Discussion LBA49, 1192MO and 1193MO
Presenter: Sai-Hong Ou
Session: Mini oral session - NSCLC, metastatic
Resources:
Slides
Webcast
Discussion LBA50, LBA51 & 1194MO
Presenter: David Gandara
Session: Mini oral session - NSCLC, metastatic
Resources:
Slides
Webcast
Discussion 828MO, 829MO and 830MO
Presenter: Andrew Davies
Session: Mini oral session - Haematological malignancies
Resources:
Slides
Webcast
Discussion 831MO and 832MO
Presenter: Ingrid Glimelius
Session: Mini oral session - Haematological malignancies
Resources:
Slides
Webcast